HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.

AbstractBACKGROUND:
Previous studies focused on the association of the telomerase reverse transcriptase (TERT) gene polymorphism rs2736100 with lung cancer did not reach the same conclusion. In the present study, we performed a meta-analysis to systematically summarize the possible association between TERT polymorphism rs2736100 and the risk for lung cancer.
METHOD:
We conducted a search of case-control studies on the association of TERT with susceptibility to lung cancer in PubMed, EMBASE, ISI Web of Science, Wanfang database in China, and Chinese National Knowledge Infrastructure (CNKI) databases. Data from eligible studies were extracted for meta-analysis. Lung cancer risk associated with rs2736100 was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULTS:
Six independent case-control studies on rs2736100 were included in our meta-analysis. Our results showed that rs2736100 was associated with the risk of lung cancer not only in an additive model (OR=1.19, 95% CI: 1.04-1.35; p=0.01), but also in a dominant model (OR=1.14, 95% CI: 1.01-1.28; p=0.03).
CONCLUSIONS:
This meta-analysis suggests that rs2736100 is associated with the risk of lung cancer.
AuthorsHui-Min Wang, Xue-Yan Zhang, Bo Jin
JournalGenetic testing and molecular biomarkers (Genet Test Mol Biomarkers) Vol. 17 Issue 12 Pg. 937-41 (Dec 2013) ISSN: 1945-0257 [Electronic] United States
PMID24283584 (Publication Type: Journal Article, Meta-Analysis, Review)
Chemical References
  • Neoplasm Proteins
  • TERT protein, human
  • Telomerase
Topics
  • Case-Control Studies
  • Female
  • Humans
  • Lung Neoplasms (enzymology, genetics)
  • Male
  • Models, Genetic
  • Neoplasm Proteins (genetics)
  • PubMed
  • Risk Factors
  • Telomerase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: